Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections

被引:7
作者
Goulenok, T. [1 ,11 ]
Seurat, J. [2 ]
de La Selle, A. [3 ]
Jullien, V. [4 ]
Leflon-Guibout, V. [5 ]
Grall, N. [2 ,6 ]
Lescure, F. X. [2 ,7 ]
Lepeule, R. [8 ,9 ]
Bertrand, J. [2 ]
Fantin, B. [2 ]
Burdet, C. [2 ,10 ]
Lefort, A. [2 ,3 ]
机构
[1] Univ Paris, Hop Bichat Claude Bernard, GHU APHP Nord, Dept Med Interne, Paris, France
[2] Univ Paris Cite, INSERM 1137, IAME, F-75018 Paris, France
[3] Univ Paris, Hop Beaujon, GHU APHP Nord, Dept Med Interne, Paris, France
[4] Univ Sorbonne Paris Nord, Hop Jean Verdier, UF Pharmacol, F-93141 Bondy, France
[5] Univ Paris, Hop Beaujon, GHU APHP Nord, Serv Microbiol, Paris, France
[6] Univ Paris, Hop Bichat Claude Bernard, GHU APHP Nord, Serv Bacteriol, Paris, France
[7] Univ Paris, Hop Bichat Claude Bernard, GHU APHP Nord, Serv Malad Infect & Trop, Paris, France
[8] Hop Univ Henri Mondor, APHP, Unite Rransversale Traitement Infect, F-94010 Creteil, France
[9] Univ Paris Est Creteil, EA Dynamyc 7380, EnvA, UPEC, F-94000 Creteil, France
[10] Univ Paris, Hop Bichat Claude Bernard, GHU APHP Nord, Biostat & Rech Clin,Dept Epidemiol, Paris, France
[11] Hop Bichat Claude Bernard, Dept Med Interne, 46 Rue Henri Huchard, F-75018 Paris, France
关键词
Clindamycin; Rifampicin; Bone and joint infection; Pharmacokinetics; Drug interaction; DRAMATIC REDUCTION; OSTEOMYELITIS; COMBINATION; LEVOFLOXACIN; EFFICACY; THERAPY; BONE;
D O I
10.1016/j.ijantimicag.2023.106885
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Oral combination of clindamycin and rifampicin is relevant for the treatment of staphylococcal osteoarticular infection (SOAIs). However, rifampicin induces CYP3A4, suggesting a pharmacokinetic interaction with clindamycin with unknown pharmacokinetic/pharmacodynamic (PK/PD) consequences. This study aimed to quantify clindamycin PK/PD markers before and during rifampicin co-administration in SOAI. Methods: Patients with SOAI were included. After initial intravenous antistaphylococcal treatment, oral therapy was started with clindamycin (600 or 750 mg t.i.d.), followed by addition of rifampicin 36 h later. Population PK analysis was performed using the SAEM algorithm. PK/PD markers were compared with and without rifampicin co-administration, each patient being his own control. Results: In 19 patients, clindamycin median (range) trough concentrations were 2.7 (0.3-8.9) mg/L and <0.05 (<0.05-0.3) mg/L before and during rifampicin administration, respectively. Rifampicin co-administration increased clindamycin clearance by a factor 16 and reduced the AUC 0-8h/MIC by a factor 15 (P < 0.005). Clindamycin plasma concentrations were simulated for 1000 individuals, without and with rifampicin. Against a susceptible Staphylococcus aureus strain (clindamycin MIC 0.0625 mg/L), >80% of individuals would reach all proposed PK/PD targets without co-administration of rifampicin, even with low clindamycin dose. For the same strain, when rifampicin was co-administered, the probability to reach clindamycin PK/PD targets dropped to 1% for %fT(>MIC) = 100% and to 6% for AUC(0-24h)/MIC > 60, even with high clindamycin dose. Conclusion: Rifampicin co-administration with clindamycin has a high impact on clindamycin exposure and PK/PD targets in SOAI, which could result in clinical failure even for fully susceptible strains. (c) 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.
引用
收藏
页数:8
相关论文
共 37 条
[1]   INVITRO INTERACTION BETWEEN RIFAMPIN AND CLINDAMYCIN AGAINST PATHOGENIC COAGULASE-NEGATIVE STAPHYLOCOCCI [J].
ARDITI, M ;
YOGEV, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :245-247
[2]   2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa [J].
Berbari, Elie F. ;
Kanj, Souha S. ;
Kowalski, Todd J. ;
Darouiche, Rabih O. ;
Widmer, Andreas F. ;
Schmitt, Steven K. ;
Hendershot, Edward F. ;
Holtom, Paul D. ;
Huddleston, Paul M. ;
Petermann, Gregory W. ;
Osmon, Douglas R. .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) :E26-E46
[3]   Handling Data Below the Limit of Quantification in Mixed Effect Models [J].
Bergstrand, Martin ;
Karlsson, Mats O. .
AAPS JOURNAL, 2009, 11 (02) :371-380
[4]   Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination [J].
Bernard, Aurelie ;
Kermarrec, Gwenole ;
Parize, Perrine ;
Caruba, Thibaut ;
Bouvet, Anais ;
Mainardi, Jean-Luc ;
Sabatier, Brigitte ;
Nich, Christophe .
JOURNAL OF INFECTION, 2015, 71 (02) :200-206
[5]   Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis [J].
Bouazza, Naim ;
Pestre, Vincent ;
Jullien, Vincent ;
Curis, Emmanuel ;
Urien, Saik ;
Salmon, Dominique ;
Treluyer, Jean-Marc .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (06) :971-977
[6]  
Christianson JAD, 2001, 41 INTERSCIENCE C AN
[7]   Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study [J].
Courjon, J. ;
Demonchy, E. ;
Cua, E. ;
Bernard, E. ;
Roger, P. -M. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (12) :2513-2518
[8]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[9]   Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections [J].
Curis, Emmanuel ;
Pestre, Vincent ;
Jullien, Vincent ;
Eyrolle, Luc ;
Archambeau, Denis ;
Morand, Philippe ;
Gatin, Laure ;
Karoubi, Matthieu ;
Pinar, Nicolas ;
Dumaine, Valerie ;
Van, Jean-Claude Nguyen ;
Babinet, Antoine ;
Anract, Philippe ;
Salmon, Dominique .
INFECTION, 2015, 43 (04) :473-481
[10]   Efficacy of a combined oral clindamycin-rifampicin regimen for therapy of staphylococcal osteoarticular infections [J].
Czekaj, Jaroslaw ;
Dinh, Aurelien ;
Moldovan, Andreea ;
Vaudaux, Pierre ;
Gras, Guillaume ;
Hoffmeyer, Pierre ;
Lew, Daniel ;
Bernard, Louis ;
Uckay, Ilker .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (11-12) :962-967